Dexcom | DXCM - Market Capitalization


Dexcom reported $32.14B in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 171.01B 12.96B Sep/2026
Align Technology USD 10.33B 1.75B Sep/2026
AtriCure USD 1.42B 28M Jun/2026
Baxter International USD 12.41B 1.4B Sep/2026
Becton, Dickinson and Co. USD 41.7B 3.07B Jun/2026
Boston Scientific USD 63.26B 181M Sep/2026
Cooper Companies USD 14.1B 1.83B Jun/2026
Dexcom USD 32.56B 6.57B Sep/2026
Edwards Lifesciences USD 52.09B 5.92B Jun/2026
Globus Medical USD 10.73B 963M Jun/2026
Insulet USD 10.55B 3.99B Jun/2026
Integra LifeSciences USD 1.27B 131M Sep/2026
J&J USD 653.61B 42.25B Sep/2026
Medtronic USD 109.3B 2.33B Jun/2026
Merit Medical Systems USD 5.15B 1.01B Sep/2026
Roche Holding CHF 270B 3.66B Jun/2026
Stryker USD 105.63B 15.07B Sep/2026
Tandem Diabetes Care USD 1.03B 276M Jun/2026
Teleflex USD 5.61B 317M Jun/2026
West Pharmaceutical Services USD 26.09B 730M Sep/2026
WK Kellogg Co USD 13.36B 2.04B Jun/2026
Zimmer Biomet Holdings USD 16.66B 845M Jun/2026